Study II Preliminary Data-includes three patients study Ib Study II Preliminary Clinical Data
To date, the phase II NMIBC clinical study has enrolled and provided the primary study treatment for 18 patients (including three patients from Phase Ib study treated at the Therapeutic Dose) for a total of 21 patients.
pg5